TrialNature communications2022

The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial.

Ravi Retnakaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.